Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

AI bests radiologists at predicting lung cancer treatment responses
More accurate response assessments could give providers an opportunity to proactively manage treatment decisions in the future.
1st patient dosed with new radiopharmaceutical targeting cancer bone pain
The treatment can offer patients a more potent, cost-effective alternative providing long-lasting relief compared to current pain regimens.
Novartis seeks to expand use of prostate therapy Pluvicto, citing positive trial results
An expanded approval could potentially double the number of patients eligible for treatment with the therapy, first approved in 2022.
How clinicians can combat health disparities in cardio-oncology
Researchers, for example, could improve disparities by performing their tests on more diverse groups of patients. Daniel Addison, MD, shared his perspective with Cardiovascular Business.
Using chest X-rays for triage could reduce lung cancer overdiagnoses
Chest X-rays could be the key to mitigating the issue of overdiagnosis in certain patient populations undergoing lung cancer screening, according to new research.

AI bests radiologists at predicting lung cancer treatment responses

More accurate response assessments could give providers an opportunity to proactively manage treatment decisions in the future.

1st patient dosed with new radiopharmaceutical targeting cancer bone pain

The treatment can offer patients a more potent, cost-effective alternative providing long-lasting relief compared to current pain regimens.

Novartis seeks to expand use of prostate therapy Pluvicto, citing positive trial results

An expanded approval could potentially double the number of patients eligible for treatment with the therapy, first approved in 2022.

Daniel Addison, MD, Director of Translational Research in the Cardiology Division and Associate Director for Survivorship and Outcomes Research in the Harold C. Simmons Comprehensive Cancer Center. He also holds the Audre and Bernard Rapport Endowed Chair in Cardiovascular Research, UT Southwestern Medical Center. explains the health disparities and inequities involved in cardio-oncology.

How clinicians can combat health disparities in cardio-oncology

Researchers, for example, could improve disparities by performing their tests on more diverse groups of patients. Daniel Addison, MD, shared his perspective with Cardiovascular Business.

Using chest X-rays for triage could reduce lung cancer overdiagnoses

Chest X-rays could be the key to mitigating the issue of overdiagnosis in certain patient populations undergoing lung cancer screening, according to new research.

As cancer therapies become increasingly targeted and complex, the need for sophisticated cardiovascular monitoring has grown in parallel. Cardiovascular Business spoke with Daniel Addison, MD, director of the cardio-oncology program at The Ohio State University and chair of the American Heart Association’s (AHA) Cardiac Imaging Committee, who said the use of multimodality imaging is transforming how clinicians manage cardiovascular risk in cancer patients and survivors.

Multimodality imaging is more important than ever to the field of cardio-oncology

“Multimodality imaging in cardio-oncology is something many of us in the field are truly excited about," Daniel Addison, MD, told Cardiovascular Business. He noted that modalities other than echocardiography are starting to play a much larger role in the treatment of these patients.

AI outperforms radiologists at predicting cancer treatment response based on imaging

These findings have the potential to change how treatment decisions are made in the future, researchers suggest.

Abbreviated MRI could become standard of care for prostate cancer diagnosis

Biparametric prostate MRIs take significantly less time than multiparametric exams, as they do not include a contrast-enhanced sequence. This also makes the abbreviated exams more cost-friendly.